The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance
Excerpt:
Tumor-bearing mice were orally dosed with vehicle or PRN1371 at a dose of 15 mg/kg b.i.d. Significant tumor growth inhibition was observed in three of the four squamous NSCLC PDX models (Table 3).